Track the 바이오플러스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바이오플러스 has published 58 public disclosures. Market capitalisation: €211.7bn. The latest transaction was disclosed on 12 March 2026 (Other). Among the most active insiders: 정현규. The full history is openly available.
58
Insider Decl.
n/a
Thresholds
n/a
12 ops.
Buy Volume
n/a
19 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,209 of 29,062 companies
56.1
score / 100
Value
45
Quality
67
FCF yld-16%
Earn yld7.1%
EV/EBITDA12.4x
ROE11%
Gross mgn67%
Net mgn17%
Debt/EBITDA2.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.